NVENTA’S CEO TO PRESENT AT TWO UPCOMING INVESTOR CONFERENCES

FOR IMMEDIATE RELEASE - October 2, 2007

San Diego, California USA - Nventa Biopharmaceuticals Corporation (TSX:NVN) announced today that Gregory M. McKee, the Company’s President and Chief Executive Officer, will present at two upcoming investor conferences:

BioContact Quebec 2007 (Quebec, Canada):
Mr. McKee is scheduled to present on Thursday, October 4th at 11:00 am (Eastern Time) in the Salle Laval Room at the Fairmont Le Chateau Frontenac.

BIO Investor Forum (San Francisco, California):
Mr. McKee is scheduled to present on Wednesday, October 10th at 1:15 pm (Pacific Time) in the Twin Peaks South Room at the Palace Hotel in San Francisco.  

A live webcast with supporting slides of this presentation will be available via:

http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=NVN.TO&item_id=1660569

The replay of the webcast at BIO Investor Forum will be available until January 10, 2008.  (Due to its length, this URL may need to be copied/pasted into your Internet browser's address field.  Remove any extra spaces if necessary.)

About Nventa Biopharmaceuticals Corporation:

Nventa is developing innovative therapeutics for the treatment of viral infections and cancer, with a focus on diseases caused by the human papillomavirus (HPV).   The corporation is publicly traded on the Toronto Stock Exchange under the symbol NVN.

For more information about Nventa Biopharmaceuticals Corporation and access to the BIO Investor Forum webcast, please visit the Company’s website located at www.nventacorp.com.

Contact:

Download a PDF file of this release